title: Intranasal apomorphine in Parkinson's disease.
authors.affiliation: Department of Neurology, Middlesex Hospital, London, UK.
authors.forename: B
authors.initials: B
authors.lastname: Kleedorfer
authors.forename: N
authors.initials: N
authors.lastname: Turjanski
authors.forename: R
authors.initials: R
authors.lastname: Ryan
authors.forename: A J
authors.initials: AJ
authors.lastname: Lees
authors.forename: C
authors.initials: C
authors.lastname: Milroy
authors.forename: G M
authors.initials: GM
authors.lastname: Stern
mesh_terms: D000281:Administration, Intranasal; D000368:Aged; D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D010865:Pilot Projects
chemical_list: D007980:Levodopa; D001058:Apomorphine